4.7 Article

Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1

期刊

LEUKEMIA
卷 26, 期 7, 页码 1555-1563

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2012.19

关键词

cell survival; oncogene; tumor suppressor gene; therapy

资金

  1. National Cancer Institute [CA 95111, P01 78890]
  2. Cancer Research UK Program [C11074/A11008]
  3. Glasgow Experimental Cancer Medicine Centre (ECMC)
  4. American-Italian Cancer Foundation (AICF)
  5. Associazione Italiana Ricerca sul Cancro (AIRC)
  6. Fondazione Cassa di Risparmio di Vignola
  7. AIRC/Marie Curie Foundation
  8. Cancer Research UK [11008] Funding Source: researchfish

向作者/读者索取更多资源

Expression of the transcription repressor Gfi-1 is required for the maintenance of murine hematopoietic stem cells. In human cells, ectopic expression of Gfi-1 inhibits and RNA interference-mediated Gfi-1 downregulation enhances proliferation and colony formation of p210BCR/ABL expressing cells. To investigate the molecular mechanisms that may explain the effects of perturbing Gfi-1 expression in human cells, Gfi-1-regulated genes were identified by microarray analysis in K562 cells expressing the tamoxifen-regulated Gfi-1-ER protein. STAT 5B and Mcl-1, two genes important for the proliferation and survival of hematopoietic stem cells, were identified as direct and functionally relevant Gfi-1 targets in p210BCR/ABL-transformed cells because: (i) their expression and promoter activity was repressed by Gfi-1 and (ii) when constitutively expressed blocked the proliferation and colony formation inhibitory effects of Gfi-1. Consistent with these findings, genetic or pharmacological inhibition of STAT 5 and/or Mcl-1 markedly suppressed proliferation and colony formation of K562 and CD34 + chronic myelogenous leukemia (CML) cells. Together, these studies suggest that the Gfi-1STAT 5B/Mcl-1 regulatory pathway identified here can be modulated to suppress the proliferation and survival of p210BCR/ABL-transformed cells including CD34 + CML cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据